ADXS

Ayala Pharmaceuticals, Inc. ADXS

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ADXS OCEA REPCF CERO THER NBCO SQZB VOQP CDT OZYMF
6M 223.90 % -84.14 % 1 940.00 % -76.50 % 900.00 % -44.53 % -8.93 % 3.33 % -70.93 % -99.64 %
YTD 268.89 % -98.84 % 3 980.00 % -97.30 % 900.00 % -66.19 % -15.00 % 3.33 % -96.50 % -99.64 %
1Y 268.89 % -99.24 % 852.38 % -98.33 % 900.00 % -84.22 % 10.87 % 3.33 % -97.57 % -99.64 %
3Y -94.73 % -99.93 % 580.00 % -99.98 % -70.59 % -94.56 % -99.19 % 3.33 % -99.97 % -99.92 %
5Y -99.69 % -99.93 % 312.16 % -99.98 % -99.58 % -98.78 % -99.81 % -69.00 % -99.97 % -100.00 %
10Y -100.00 % -99.93 % -85.53 % -99.98 % -100.00 % -99.05 % -99.81 % -92.25 % -99.97 % -100.00 %
From the beginning -100.00 % -99.93 % -74.50 % -99.98 % -100.00 % -100.00 % -99.81 % -100.00 % -99.97 % -100.00 %

Dividend